A special interview with Melissa Wilson, PA-C, MPAS, and Krista Rubin, MS, FNP-BC, a Family Nurse Practitioner (FNP-BC) at Mass General Cancer Center in Boston, MA, AIM at Skin Cancer's "Ask a Nurse," and host of a new skin cancer webinar series, "Skin Cancer & YOU.
Melissa and Krista discuss the latest advancements in nonmelanoma skin cancer treatment. Discover the groundbreaking breakthroughs that are shaping the future of skin cancer care.
Nonmelanoma skin cancers, including basal cell carcinoma and squamous cell carcinoma, are the most common types of skin cancer. While these cancers are typically slow-growing and rarely spread to other parts of the body, advanced cases can be more challenging to treat.
Treatment options for advanced nonmelanoma skin cancers may include surgery, radiation therapy, targeted therapy, or immunotherapy. The choice of treatment depends on various factors such as the size and location of the tumor, the overall health of the patient, and whether the cancer has spread to other parts of the body.
Early detection and prompt treatment are crucial in managing advanced nonmelanoma skin cancers. Regular skin checks by a dermatologist can help identify any suspicious lesions early on. It is also important for patients to protect their skin from harmful UV rays by wearing sunscreen and protective clothing.
Krista Rubin MS, FNP-BC
Nurse Practitioner, Center for Melanoma, Massachusetts General Hospital, AIM at Skin Cancer's "Ask a Skin Cancer Nurse"
Krista Rubin is a Nurse Practitioner in the Melanoma Disease Center at Massachusetts General Hospital in Boston. She has been involved in the care of patients with melanoma and nonmelanoma skin cancers for the past 20+ years. She has extensive expertise in the diagnosis, management and treatment of patients with both early and late-stage skin cancers. She lectures internationally and has authored numerous articles on the topic of skin cancer.